These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17875689)

  • 1. Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis.
    Lapointe J; Li C; Giacomini CP; Salari K; Huang S; Wang P; Ferrari M; Hernandez-Boussard T; Brooks JD; Pollack JR
    Cancer Res; 2007 Sep; 67(18):8504-10. PubMed ID: 17875689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer.
    Ishkanian AS; Mallof CA; Ho J; Meng A; Albert M; Syed A; van der Kwast T; Milosevic M; Yoshimoto M; Squire JA; Lam WL; Bristow RG
    Prostate; 2009 Jul; 69(10):1091-100. PubMed ID: 19350549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
    Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative analysis of genomic aberrations associated with prostate cancer progression.
    Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
    Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimum altered regions in early prostate cancer progression identified by high resolution whole genome tiling path BAC array comparative hybridization.
    Watson SK; Woolcock BW; Fee JN; Bainbridge TC; Webber D; Kinahan TJ; Lam WL; Vielkind JR
    Prostate; 2009 Jun; 69(9):961-75. PubMed ID: 19267368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature.
    Lapointe J; Malhotra S; Higgins JP; Bair E; Thompson M; Salari K; Giacomini CP; Ferrari M; Montgomery K; Tibshirani R; van de Rijn M; Brooks JD; Pollack JR
    Am J Surg Pathol; 2008 Feb; 32(2):205-9. PubMed ID: 18223322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays.
    Clark J; Edwards S; Feber A; Flohr P; John M; Giddings I; Crossland S; Stratton MR; Wooster R; Campbell C; Cooper CS
    Oncogene; 2003 Feb; 22(8):1247-52. PubMed ID: 12606952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of an array comparative genomic hybridization (CGH) technique in detecting DNA copy number aberrations: comparison with conventional CGH and loss of heterozygosity analysis in prostate cancer.
    Yano S; Matsuyama H; Matsuda K; Matsumoto H; Yoshihiro S; Naito K
    Cancer Genet Cytogenet; 2004 Apr; 150(2):122-7. PubMed ID: 15066319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA sequence copy number aberrations in prostate cancers: a comparison of comparative genomic hybridization data between Japan and European countries.
    Matsuda K; Matsuyama H; Hara T; Yoshihiro S; Oga A; Kawauchi S; Furuya T; Izumi H; Naito K; Sasaki K
    Cancer Genet Cytogenet; 2004 Jul; 152(2):119-23. PubMed ID: 15262429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies.
    Sun J; Liu W; Adams TS; Sun J; Li X; Turner AR; Chang B; Kim JW; Zheng SL; Isaacs WB; Xu J
    Prostate; 2007 May; 67(7):692-700. PubMed ID: 17342750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma.
    Ferreira BI; Alonso J; Carrillo J; Acquadro F; Largo C; Suela J; Teixeira MR; Cerveira N; Molares A; Goméz-López G; Pestaña A; Sastre A; Garcia-Miguel P; Cigudosa JC
    Oncogene; 2008 Mar; 27(14):2084-90. PubMed ID: 17952124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically distinct and clinically relevant subtypes of glioblastoma defined by array-based comparative genomic hybridization (array-CGH).
    Korshunov A; Sycheva R; Golanov A
    Acta Neuropathol; 2006 May; 111(5):465-74. PubMed ID: 16557391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic analysis of prostate carcinoma specimens obtained via ultrasound-guided needle biopsy may be of use in preoperative decision-making.
    Teixeira MR; Ribeiro FR; Eknaes M; Waehre H; Stenwig AE; Giercksky KE; Heim S; Lothe RA
    Cancer; 2004 Oct; 101(8):1786-93. PubMed ID: 15386312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines.
    Hermans KG; van Alewijk DC; Veltman JA; van Weerden W; van Kessel AG; Trapman J
    Genes Chromosomes Cancer; 2004 Mar; 39(3):171-84. PubMed ID: 14732919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of recurrent copy number loss at Yp11.2 involving TSPY gene cluster in prostate cancer using array-based comparative genomic hybridization.
    Vijayakumar S; Hall DC; Reveles XT; Troyer DA; Thompson IM; Garcia D; Xiang R; Leach RJ; Johnson-Pais TL; Naylor SL
    Cancer Res; 2006 Apr; 66(8):4055-64. PubMed ID: 16618725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
    Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
    Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer.
    Nanni S; Priolo C; Grasselli A; D'Eletto M; Merola R; Moretti F; Gallucci M; De Carli P; Sentinelli S; Cianciulli AM; Mottolese M; Carlini P; Arcelli D; Helmer-Citterich M; Gaetano C; Loda M; Pontecorvi A; Bacchetti S; Sacchi A; Farsetti A
    Mol Cancer Res; 2006 Feb; 4(2):79-92. PubMed ID: 16513839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.